Stryker Trauma and Extremities

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stryker Trauma and Extremities sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).

30 total trials 2 currently recruiting 11 completed later-stage tilt top decile by trial count

Stryker Trauma and Extremities: 30 sponsored US clinical trials, 2 recruiting.

Stryker Trauma and Extremities sponsors 30 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 11 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Femoral Fracture, with 3 trials.

Top-decile sponsor footprint

Stryker Trauma and Extremities ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 0/100

11 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (52.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

30 total, page 1 of 1

RECRUITING

A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System

NCT07118501
RECRUITING

Perform Humeral System Study

NCT05067543
ACTIVE NOT RECRUITING

Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study

NCT05868148
ACTIVE NOT RECRUITING

Perform® Humeral System - Fracture Study (PFX)

NCT05773352
ACTIVE NOT RECRUITING

Post Market Clinical Evaluation of Gamma 4

NCT05523635
ACTIVE NOT RECRUITING

Pyrocarbon Clinical Follow-up Study

NCT05049993
ACTIVE NOT RECRUITING

INFINITY™ With ADAPTIS™ Technology Study

NCT04594993
ACTIVE NOT RECRUITING

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF

NCT04015154
ACTIVE NOT RECRUITING

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

NCT04015128
COMPLETED

Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability

NCT06829667
COMPLETED NA

Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talofibular Ligament (ATFL) to Treat Lateral Ankle Instability

NCT06638138
TERMINATED

Lower Extremity Fixation In Neuropathic Patients Study

NCT04607044
TERMINATED

Wright Foot & Ankle Post-Market Observational Study

NCT04118894
TERMINATED

A Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System

NCT04089371
COMPLETED

A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System

NCT04015167
TERMINATED

Collecting Orthopedic Safety and Performance Data Using Surgeons Clinical Outcomes Registry (SCOR)

NCT04032444
TERMINATED

A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System

NCT03880955
TERMINATED

A Post-Market Clinical Evaluation of the ReUnion TSA System

NCT03858517
TERMINATED

INFINITY™Total Ankle Replacement Follow-up

NCT03277989
COMPLETED

Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty

NCT02525783
TERMINATED

Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients

NCT02047955
COMPLETED

BioFiber Scaffold Post-Market Observational Study

NCT01849458
COMPLETED NA

Intramedullary Nail Versus Sliding Hip Screw Inter-Trochanteric Evaluation

NCT01380444
COMPLETED Phase 3

Simpliciti IDE Trial; Replacing the Humeral Head in Total Shoulder Arthroplasty

NCT01390038
TERMINATED NA

INBONE™ Total Ankle Prosthesis With Long Talar Stem

NCT01641848
TERMINATED

INBONE Total Ankle Arthroplasty(TAA)Using Calcaneal Stem Fixation

NCT01366989
COMPLETED NA

Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers

NCT01353495
COMPLETED

Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients

NCT01288586
COMPLETED NA

Outcomes in Rotator Cuff Repair Using Graft Reinforcement

NCT01025037
COMPLETED NA

Use of Graft Jacket for Rotator Cuff Repair

NCT00456781

Phase Distribution

PhaseTrial count
Phase 3 1

Therapeutic Areas

Femoral Fracture 3
Avascular Necrosis 2
Osteoarthritis Shoulder 2
Traumatic Arthritis 2
Traumatic Arthritis of Right Shoulder Region (Diagnosis) 1
Fracture, Humeral 1
Osteoarthritis of the Shoulder 1
Revision of Other Devices if Sufficient Bone Stock Remains 1
Fracture Humerus 1
Traumatic Arthropathy of Shoulder 1

Where Stryker Trauma and Extremities enrollment is open (later-stage tilt)

2 recruiting of 30 indexed (7% open); 11 completed (37%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Femoral Fracture (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Stryker Trauma and Extremities: open-pipeline peers nationwide

Peers matched on 30 registered trials and 7% open enrollment, not the therapeutic-area sidebar.

Stryker Trauma and Extremities sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 101520253035 0%5%10%15%20% Total trials Recruiting share Stryker Trauma and ExtremitiesBiotronikCharles Drew University of Medicine and ScienceChiesi Farmaceutici S.p.A.Debiopharm InternationalBaylor Breast Care CenterGeron CorporationGuerbetJoanne Kurtzberg, MD
Stryker Trauma and Extremities sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Stryker Trauma and Extremities sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 30 trials (± recruiting share)

Sponsors near 7% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Stryker Trauma and Extremities page

30 registered trials is a research-attention snapshot, not an endorsement of Stryker Trauma and Extremities or any single study.

  • 2 of Stryker Trauma and Extremities's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Femoral Fracture is the condition Stryker Trauma and Extremities studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Femoral Fracture trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Stryker Trauma and Extremities pipeline card: 30 registered trials from official public datasets.Report a data error.